Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase vs Placebo in Normotensive Pulmonary Embolism With Right Ventricular Dysfunction
NCT00222651Phase 2Terminated
- Sponsor
- University of Perugia
- Start
- Jul 2004
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary embolism (PE) comparing Tenecteplase + UFH with Placebo + UFH (2 arms). Primary endpoint: Clinically relevant reduction of Right Ventricular Dysfunction at 24 hours. Started Jul 2004; status: terminated.
02
Drugs
tenecteplase
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00222651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00222651.